Traditional ICD induction approaches (chemotherapy/radiotherapy) struggle to effectively reverse the effects of an immunosuppressive TME (e.g., Treg infiltration, PD-L1 upregulation) due to systemic toxicity, poor tumor targeting, and insufficient immunogenicity [46,47]. The gene discussed is CD274; the disease is neoplasm.